3 research outputs found

    Prevalence of rhesus negativity among pregnant women

    Get PDF
    Background: Hemolytic disease of the newborn (HDN), secondary to Rhesus D (Rh D) iso - immunization, contributes significantly to perinatal morbidity and mortality. The objective of the study was to determine the frequency of Rh factor in this region, which would not only help in blood transfusion services but also eliminate the risk of Erythroblastosis fetalis in the neonates.Methods: A two year retrospective study of rhesus negative pregnant women was carried out at Tertiary care center, Modern Government Maternity Hospital, Petlaburz, Hyderabad, from January 2014 to December 2015.Results: The prevalence rate of Rh D negative women for antenatal care, were 895 (4.29%). Out of that 304 (33.96%) of the Rh D negative women were of blood group B followed by blood group O of 292(32.62%), blood group A of 218 (24.35%) and blood group AB of 81 (9.05%), respectively.Conclusions: The prevalence of Rh D negative women is low when compared to Rh D positive women.There is a need for adequate counselling of pregnant women on the importance of Rh D negative factor during the antenatal period in order to prevent hemolytic disease of the newborn

    A rare case of complete hydatidiform mole with a live fetus: a case report

    Get PDF
    Twin pregnancy with complete hydatidiform mole represents a very rare obstetric problem resulting in a healthy take-home baby with only 56 cases documented in detail in literature. The main issue is to differentiate between two diagnoses: dichorionic twin pregnancy with normal fetus (46 chromosomes, 23 maternal and 23 paternal) and complete molar pregnancy (46 chromosomes, all paternal) and singleton pregnancy consisting of a triploid fetus with partial hydatidiform mole placenta (69 chromosomes, 23 maternal and 46 paternal). Management of such cases is always problematic because the possibility of fetal survival should always be weighed against the risk of complications of molar pregnancy. The specimen was received for histopathological examination and fixed in 10% formalin for processing. After gross analysis representative sections were given for tissue processing. Sections were processed routinely with paraffin embedding and stained with haematoxylin and eosin. In the present report a case of   25-year-old woman who presented to the center referred from peripheral center with 27 weeks of gestation, diagnosed as twin pregnancy with molar pregnancy and single live fetus

    Original research article on cystic ovarian lesions diagnosed as teratomas - a 2 year study in a tertiary care hospital

    Get PDF
    Background: The incidence of dermoid cyst accounts for approximately 20% of all ovarian tumours. They occur more commonly in reproductive age group of women and are usually unilateral. This study is conducted to evaluate the clinical and pathologic presentation of mature cystic teratomas. Dermoid cyst is the most common type of ovarian germ cell tumor.Methods: A 2yr retrospective and prospective study is done at tertiary care centre hospital of which around 180 patients with ovarian cysts were included of which 29 cases are diagnosed as teratomas are included. . Hysterectomy specimens along with adnexa were received for histopathological examination, and tissues were fixed in 10% formalin for processing.  Sections were processed routinely with paraffin embedding and stained with haematoxylin and eosin.Results: Cystic teratomas constituted 16.1% of all ovarian cystic lesions diagnosed and treated at our institution during the study period. The median of age was 34years. Abdominal or pelvic pain was the most frequent symptom for presentation in 62%of the cases. The rate of bilateral cystic teratomas of the ovary was 7%. The incidence of torsion was 3.3%, and was the highest in all complications. Histopathological evaluation has detected 96.6 % cases of mature teratomas, and 3.4% cases of immature teratomas.Conclusions: Mature cystic teratoma is the most common germ cell tumor and accounts for about 33% of all ovarian neoplasm
    corecore